Module 4 Flashcards
Reaction Time: Fast Mediators: Neurons Type of Message: Electrical impulse Response Target: External environment Linking Mechanism: Nerves and synapses Effectors: Muscles and glands Function: Nervous coordination
NERVOUS CONTROL
Reaction Time: Slow Mediators: Hormones Type of Message: Organic message Response Target: Internal environment Linking Mechanism: Blood and circulatory system Effectors: Organ systems Function: Chemical coordination
HORMONAL CONTROL
released by axon terminals and act locally to control cell functions
NEUROTRANSMITTERS
- local chemical messengers secreted by cells into the extracellular fluid & affect neighboring cells of a different type
- example: Histamine
PARACRINES/JUXTACRINE
- Affects cells of the same type
- secreted by cells into the ECF and affects the function of the same cells that produced them by binding to cell surface receptors
AUTOCRINES
- are peptides secreted by cells into the ECF & can function as autocrines, paracrines or endocrine hormones
- Examples:
a. interleukins & lymphokines – secreted by helper cells & act on other cells of the immune system
b. Leptin (adipokines) – secreted by adipocytes
CYTOKINES
- secreted by neurons into the circulating blood and influence the function of cells at another location in the body
- examples ADH, OTC, and hypophysiotropic hormone
NEUROENDOCRINE HORMONES
- Greek word – HORMAEIN (to arouse or excite)
- released by endocrine glands into blood stream and influence function of target cells
- some affect almost all cells and organs (GH, Thyroid hormone, Catecholamines)
- other affect specific tissues (ACTH, TSH, FSH & LH)
Endocrine hormones
- secreted by ductless glands in the endocrine system
- play important role in homeostasis
- essential to the maintenance of the life and well being of an individual and of the species
Endocrine hormones
- Chemical Messengers
- secreted into the blood and acts on another location
Hormones
Main site of inactivation of hormone
e.g. Estrogen in males
LIVER
Mechanism for removal of hormone
e.g. urine metabolites like VMA), LIVER (bile, feces
KIDNEYS
General Characteristics of Hormones
- Secreted by specific group of cells
- Thrown directly into circulation
- Exert effects on target tissues which are distant from the source of hormone
- Do not create an additional or new function, only modify or alter functions that already exists.
- Rate of secretion fluctuates. Increases when there is a need for it; minimal when need not present.
- Do not stay in the circulation forever
Hormone Classes
- PROTEIN HORMONE
- BIOGENIC AMINES
- STEROID HORMONE
- More common hormone class; Stored in vesicles
PROTEIN HORMONE
- derivatives of tyrosine
thyroid hormones (T3 and T4)
adrenal medullary hormones - derivative of histidine:
histamine (mast cells in connective tissues) - derivatives of tryptophan
melatonin (pineal gland)
serotonin (blood platelets)
BIOGENIC AMINES
- derivative of Cholesterol
- Synthesized as needed
STEROID HORMONE
Produces new proteins from DNA
Lipid-soluble
Reflection Coefficient closer to 0
STEROID HORMONES
Modifies existing proteins
Water-soluble
Reflection Coefficient closer to 1
PROTEIN HORMONES
- Transmembrane proteins loop in and out of the cell membrane seven times
- Make use of G-Proteins
G-PROTEIN LINKED HORMONE RECEPTORS
- Passes through the membranes only once
- Makes use of intracellular enzymes directly
- E.g. Leptin and its use of Tyrosine Kinase
ENZYME-LINKED HORMONE RECEPTORS
- Heterotrimeric GTP-binding Proteins
- Act as TRANSDUCERS
- Link hormone receptors with 2nd messenger systems (Intracellular Enzymes and Ion Channels)
- May be Gs Protein (stimulatory) or Gi Proteins (inhibitory)
- 3 subunits: alpha, beta, gamma
G Proteins
- Most common 2nd Messenger System
- MECHANISM
Alpha subunit of G proteins activates Adenylate cyclase and together with ATP —> forms cAMP —> activates protein kinase A
cAMP/cGMP System
- Used by all Hypothalamic Hormones EXCEPT CRH
- Mediates smooth muscle contraction by hormone/neutrotransmitter (e.g. Motilin in the GI)
- MECHANISM
Phospholipase C —> PIP2 —> PIP2 splits into IP3(releases Calcium) and DAG (activates protein kinase C)
Phospholipid System (IP3/DAG)
- Used by Insulin, Growth factors, EPO, Leptin
- Enzyme-linked
Tyrosine Kinase
- Must be transported bound to a protein in the blood
- Active form: FREE, UNBOUND FORM
Lipid Soluble Hormones
Hormone Secretion, Transport and Clearance
- Onset of Hormone Effects (Varies from seconds (NE, Epi) to months (T3, GH))
- Very little amount needed to produce effect
- Number of Hormone Receptors (never constant)
Mechanism of Hormonal Action
On the target cell, the hormone in combination
with the receptor cells act by any of the following
mechanisms:
- Alternating the permeability of cell membrane
- Neurotransmitter substances - Activating the intracellular enzyme - Protein hormones and catecholamines
- Activating the gene - Thyroid and steroid hormones
(Regulation of Hormone Secretion)
- “Products inhibit Precursors”
- More common
- E.g. Cortisol inhibiting ACTH Secretion from the Pituitary
NEGATIVE FEEDBACK
(Regulation of Hormone Secretion)
- “Products stimulate Precursors”
- Rare, exploding
- E.g. surge of LH before ovulation, Oxytocin during delivery and lactation
POSITIVE FEEDBACK
(Regulation of Hormone Receptors)
Decrease in:
- Receptor Number
- Receptor Affinity
- E.g. in the uterus, progesterone down-regulates its own receptor and the receptor for estrogen
DOWN-REGULATION OF RECEPTORS
(Regulation of Hormone Receptors)
Increase in:
- Receptor Number
- Receptor Affinity
- E.g. in the ovary, estrogen up-regulates its own receptor and that of LH
UP-REGULATION OF RECEPTORS
Hormone Interaction
- SYNERGISTIC EFFECTS
- PERMISSIVE EFFECTS
- ANTAGONISTIC EFFECTS
SYNERGISTIC EFFECTS
ADDITIVE EFFECTS - same function
- E.g. Epinephrine and NE effects on the heart
COMPLEMENTARY EFFECTS - different function but end product is the same
- E.g. FSH and Testosterone effects on spermatogenesis
- permit the other hormone to do its function
- E.g. Cortisol has permissive effects on Epi and NE with regards to blood vessels; T3 has __ on Epi with regards to lipolysis
PERMISSIVE EFFECTS
- inhibit one another
- E.g. Estrogen blocking Prolactin effects on the breasts during pregnancy
ANTAGONISTIC EFFECTS
- Equal to the rate of disappearance of hormone from the plasma/concentration of hormone in each milliliter of plasma
- Mechanisms: Tissue Destruction, Tissue binding, Bile Excretion, Urine Excretion
Metabolic Clearance Rate
- problem pertaining to the target organ or peripheral gland
Primary Endocrine disease
- problem is in the pituitary gland
Secondary Endocrine Disease
- problem is in the hypothalamus
Tertiary Endocrine Disease
- Causes growth of all or most body tissues
- Prerequisite: SUFFICIENT INSULIN ACTIVITY and CHO
- Stimulates increased: MITOSIS, CELL SIZE AND CELL NUMBER
- Promotes differentiation of specific cell types (e.g., bone growth cells)
- Single chain; 191 AA residues
- Pulsatile secretion
Growth Hormone (Somatotropin)
- Relatively low during the day
- ↑s during first 2 hours of deep sleep
- Regular nocturnal peak: 1 hour after Stage 3 or 4 deep sleep onset
- Preceded by nocturnal plasma GHRH peak
Growth Hormone (Somatotropin)
- Biological t½ = 20 mins
- Serum GH level varies widely
- GH secretion in women > men
(highest before ovulation) - Rate: highest in late puberty, neonate; lowest in older/obese adults, hypothyroidism, Type 2 DM
Growth Hormone (Somatotropin)
Growth Hormone (Somatotropin): AVERAGE PLASMA CONCENTRATION
- 5-20 years old: 6 ng/ml
- 20-40 years old: 3 ng/ml
- 40-70 years old: 1.6 ng/mL
Pattern of GH Secretion: Pre-puberty
- Stabilization of 24-hour pulsatile GH secretion rates (200-600 μg/day)
- Approximate those in post-pubertal young adults
Pattern of GH Secretion: Puberty
- 1.5-3-fold ↑ pulsatile GH secretion
- With proportionate ↑ in plasma insulin-like growth factor-I (IGF-I)
- Physiological GH hypersecretion driven by onset of ↑ sex-steroid hormones
- Correlate with rate of ↑ in height
- GHRH response: tall adults > ave height
Pattern of GH Secretion: Puberty
- Final height (FH) may partly be determined by inherent GH secretory capacity
- In normal children with idiopathic short stature - GH treatment significantly ↑ FH in a dose-dependent manner
Mean gain = 1.3 SDS (8 cm) and a broad range of response from no gain to 3 SDS compared to a mean gain of 0.2 SDS in the untreated controls. (Albertsson-Wikland, 2008)
Pattern of GH Secretion: Adulthood
- Starting 18-25 y/o GH secretion ↓s up to pre-pubertal level (
Pattern of GH Secretion: Aging
- ↓ GH secretion
- Correlated to
- ↑ total body & visceral fat %; Muscle wasting, ↓ physical fitness, ↓ [testosterone ] or menopause
- Partly responsible for: ↓ lean body mass; ↓ protein synthesis; ↓ metabolic rate and ↑ adipose tissue
Excessive somatostatin release can lead to
↓/deficiency GHRH secretion in aging human
- is a Protein anabolic hormone, Lipolytic hormone, Diabetogenic hormone, Growth promoter hormone
Growth hormone
True or False
Linear bone growth does not happen when the epiphyseal plates close
True
Growth Hormone: Effect on Protein Metabolism
Anabolic
- Stimulates AA uptake and CHON deposition
- ↓ protein breakdown
- Effect begins in minutes
- Stimulates collagen synthesis
Produces:
- (+) Nitrogen balance
- ↓ BUN and AA (Amino Acids)
- ↑ excretion of AA 4-hydroxyproline
Growth Hormone: Effect of Carbohydrate Metabolism
- Normal GH level needed to maintain normal pancreatic Islet function which can lead to decreased insulin if no GH
- decreased CHO use can DIABETOGENIC
- Mechanism: Impaired insulin function from increased FA blood concentration
Growth Hormone: Effect on Electrolyte Metabolism
- ↑ GI absorption of Ca2+
- ↓ Na+ and K+ excretion – most probably due to diversion from kidneys to growing tissues
- (+) Phosphorus balance; ↑ plasma Phosphorus
Growth Hormone: Effect on Fat Metabolism
- Lipolytic
- ↑ FA mobilization & use for energy
- ↑ FA to Acetyl CoA conversion
- ↑ FFA may contribute to GH-induced insulin resistance
- Effect begins in hours
Summary of GH Actions
- ↑ protein synthesis rate in most body cells
- ↓ Adiposity:
- ↑ lipolysis / FA mobilization from adipose tissue
- ↑ FA in blood
- ↑ FA use as fuel
- ↓ glucose uptake
- ↑ linear growth
- ↑ organ size & function
- ↑lean body mass
- Mediate action of GH on chondrocytes & linear growth, protein metabolism and organ size, and lean body mass
- Polypeptide growth factors
- Secreted by liver and other tissues
Somatomedins (Insulin-like Growth Factors I & II)
Types of Somatomedins
- IGF-I (Somatomedin C)
2. IGF-II
- skeletal and cartilage growth
- Increases in parallel with GH
- Both GH- and insulin-dependent
- Lower in old age: angina pectoris, myocardial infarction, atherosclerosis
- Earlier death in aging men with low levels
IGF-I (Somatomedin C)
- fetal growth regulator; increased by PRL GH and somatomedins can act both in cooperation and independently to stimulate pathways that lead to growth
IGF-II
Stimulate GH Secretion
- decreased glucose
- decreased FFA
- increased AA
- starvation, fasting and protein deficiency
- Stress
- Excitement
- Deep Sleep (stages 3 or 4)
- Puberty
- Estrogen, androgen and thyroid hormone
- GABA
- Enkephalins
- Prostaglandin
Neurotransmitters that stimulate GH secretion
Dopamine
Acetylcholine
Serotonin
Norepinephrine
Inhibit GH secretion
- Somatostatin
- Increased glucose and FFA
- Somatomedins (IGF)
- GH
- Beta adrenergic agonist
- Cortisol
- Senescence
- Obesity
- Pregnancy
- Excessive activation of somatotropes or (+) acidophilic pituitary tumors
- Excessive GH before puberty/ fusion of epiphyses with shaft
- Rapid growth of all body tissues
- Hyperglycemia due to Eventual degeneration of overactive pancreas and can lead to DM
- Panhypopituitarism in most, if untreated: Death by early adulthood
Gigantism
other cells in the pituitary are unfunctional
Panhypopituitarism
Management for Gigantism
- microsurgical tumor removal
- Pituitary gland irradiation
- Excessive GH after puberty / epiphyseal fusion with shaft
- Thicker and enlarged bones
Hands, feet
Membranous bones (cranium, nose, forehead, supraorbital ridge, mandible, vertebrae) - Continued growth of soft tissues (tongue, liver, kidneys)
- Prognathism, huge brows, huge tongue, large hands with spade fingers
- Deep guttural voice
- Oily skin
Acromegaly
- a type of GH excess
- Joint deformities or frank arthritis
- Secondary DM
- Sleep apnea
- Kyphosis
↑ coronary risk:
- Poor glucose tolerance
- Hypertension
- Lipid problems
- Life shorter by average 10 years (vs. normal person)
Acromegaly
Management for Acromegaly
Normalized by treatment of adenoma (surgery, octreotide, radiation)
Ocreotide - somatotropin analog
If adult onset – typically with other Anterior Pituitary hormone deficiencies
If childhood onset – dwarfism
Growth Hormone Deficiency
- ↓ secretion of all AP hormones
- May be congenital, slowly or suddenly develop
Panhypopituitarism
Causes of Panhypotituitarism
- Pituitary tumor
- Suprasellar cysts
- Enlarged Rathke’s pouch remnants
- Pituitary infarction and necrosis from post-partum hemorrhage (Sheehan syndrome)
Causes:
Panhypopituitarism during childhood
- Hypothalamic dysfunction, GHRH deficiency
- Pituitary destruction, GH deficiency
Isolated GH deficiency
- Biologically incompetent GH
- GH receptor deficiency
(Pituitary) Dwarfism
Causes
- Unresponsive GH receptor (Laron dwarf/ GH insensitivity)
- Hereditary inability to form somatomedin C (IGF-I) (African pygmy; Levi-Lorain dwarf)
(Pituitary) Dwarfism
(Pituitary) Dwarfism: Manifestations:
- Proportional body parts
- Short stature
- Delayed skeletal maturation
- Greatly ↓ development rate
- Does not go through puberty
- Insufficient gonadotropic hormones for sexual maturation
- If only GH deficient (1/3) → mature sexually & reproduce
Panhypopituitarism in Adult: Causes
- Pituitary destruction
- Tumors: Pituitary adenoma, craniopharyngioma, chromophobe tumors
- Surgery, radiation, trauma
- Sheehan’s syndrome
- Empty sella syndrome
- Stroke
- Infectious meningitis (e.g., TB meningitis)
- Vascular problems (e.g., cavernous sinus thrombosis, sarcoidosis)
- Post-surgical cure of acromegaly
Panhypopituitarism in Adult: Manifestation
- Hypothyroidism (e.g., lethargy)
- Depressed glucocorticoid production by adrenals (e.g., weight gain)
- Suppressed gonadotropic hormone secretion (e.g., lost sexual function)
Panhypopituitarism in Adult: Treatment
Most signs & symptoms treatable by adrenocortical and thyroid hormones
Medical Uses of Human Growth Hormone
- Dwarfism and replacement therapy in growth-deficient children - Human GH synthesized by E. coli
- if purely GH deficiency → completely treatable if given early - Turner’s syndrome -2nd X chromosome in females either absent or deformed → growth & development problems
- Renal insufficiency (kidney failure)
- HIV - to treat muscle wasting
Medical Uses of Human Growth Hormone 2
- Anti-aging:
- Increased protein deposition, esp. in muscles
- ↓ fat deposits
- Feeling of invigoration of energy
- GH + exercise: ↑ type II muscle fibers in elderly - Physical performance enhancer in sports
- Used for perceived anabolic effects on muscle growth and recovery (e.g., in weight lifting, body building, football, etc.)
- Combined with anabolic steroids, erythropoietin
- Studies: no ↑ muscle size or strength after hGH injection
-10-20% Hormone product: Adrenocorticotropic Hormone (ACTH) Stain Affinity: Basophilic Hypothalamic Hormone Control: CRH Target: Adrenal, Adipose Peripheral Hormone Involved: Cortisol
Corticotrope
- 30-50%
Hormone product: Growth Hormone (GH) to Somatotropin
Stain Affinity: Acidophilic
Hypothalamic Hormone Control: GHRH, GHIH (somatostatin)
Target: All Tissues (major in LIVER)
Peripheral Hormone Involved: Insuline-like growth factor-I (IGF-I)
Somatotrope
- 10-15% Hormone product: Follicle Stimulating Hormone (FSH); Luteinizing Hormone (LH) Stain Affinity: Basophilic Hypothalamic Hormone Control: GnRH Target: GONADS
Peripheral Hormone Involved: Estrogen Progesterone Testosterone Inhibit
Gonadotrope
10-30% Hormone product: Prolactin (PRL) Stain Affinity: Acidophilic Hypothalamic Hormone Control: PIH Target: Breast, Gonads Peripheral Hormone Involved: None
Lactotrope (Mammotrope)
3-5%
Hormone product: Thyroid Stimulating Hormone (TSH)
Stain Affinity: Basophilic
Hypothalamic Hormone Control: TRH
Target: Thyroid Gland
Peripheral Hormone Involved: Triode-thyronine
Thyrotrope
▪ Also called the Neurohypophysis
▪ Composed mainly of glial-like cells called pituicytes
POSTERIOR PITUITARY GLAND
▪ do not secrete hormones
▪ act to support large numbers of terminal nerve fibers and terminal nerve endings from nerve tracts that originate in the supraoptic and paraventricular nuclei of the hypothalamus
Pituicytes
▪ Anti-diuretic hormone (ADH) or vasopressin and Oxytocin
▪ Synthesized in the cell bodies of the supraoptic and paraventricular nuclei
▪ Transported with “carrier” proteins called NEUROPHYSINS down to the nerve endings in the neurohypophysis (requires several days)
Neurohypophysial Hormones
▪ ADH is formed primarily in the supraoptic nuclei
▪ Oxytocin is formed primarily in the paraventricular nuclei
▪Each of these nuclei can synthesize about one sixth as much of the second hormone as of its primary hormone
Neurohypophysial Hormones
▪ Both are polypeptides, each containing nine amino acids
▪ Vasopressin: Cys-Tyr-Phe-Gln-Asn-Cys-Pro-ArgGlyNH2
▪ Oxytocin: Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-GlyNH2
▪ The similarity of the molecules explains their partial functional similarities
ADH and Oxytocin
▪ Injection (as small as 2 nanograms) can cause decreased excretion of water by the kidneys
▪ Without this hormone, the collecting tubules and ducts become almost impermeable to water and allows extreme loss of water into the urine
▪ causes insertion of aquaporins which causes absorption of water from the collecting tubules and ducts by osmosis
Anti-diuretic Hormone (ADH)
Vasoconstrictor Effect of ADH
▪ Low concentrations of ADH cause water reabsorption
▪ Higher concentrations of ADH have a potent effect of constricting the arterioles throughout the body
▪ Stimulus: decreased blood volume
▪ Decreased stretch signal from atrial stretch receptors, baroreceptors of the carotid, aortic, and pulmonary regions
Regulation of ADH
▪ Secretion of ADH primarily regulated by osmotic & volume stimuli
▪ Most important physiologic stimulus for ADH secretion: ↑ plasma osmolarity
▪ Hypovolemia or volume contraction also potent stimulus
▪ H2O is conserved in the body while Na & other solute continue to be excreted in the urine → causes dilution of the solutes in the ECF → correcting the initial excessively concentrated ECF
- State of excess free water excretion
Manifested by :
- Excretion of excessive amounts of dilute urine
- Excessive thirst
- Reduction of fluid intake will not affect the concentration of the urine
Diabetes Insipidus (DI)